These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 32902894

  • 1. Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden.
    Khalili H, Everhov ÅH, Halfvarson J, Ludvigsson JF, Askling J, Myrelid P, Söderling J, Olen O, Neovius M, SWIBREG Group.
    Aliment Pharmacol Ther; 2020 Aug; 52(4):655-668. PubMed ID: 32902894
    [Abstract] [Full Text] [Related]

  • 2. Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn's Disease in Italy.
    Dovizio M, Hartz S, Buzzoni C, Redondo I, Nedeljkovic Protic M, Birra D, Perrone V, Veronesi C, Degli Esposti L, Armuzzi A.
    Adv Ther; 2024 Jun; 41(6):2282-2298. PubMed ID: 38619721
    [Abstract] [Full Text] [Related]

  • 3. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
    van der Valk ME, Mangen MJ, Leenders M, Dijkstra G, van Bodegraven AA, Fidder HH, de Jong DJ, Pierik M, van der Woude CJ, Romberg-Camps MJ, Clemens CH, Jansen JM, Mahmmod N, van de Meeberg PC, van der Meulen-de Jong AE, Ponsioen CY, Bolwerk CJ, Vermeijden JR, Siersema PD, van Oijen MG, Oldenburg B, COIN study group and the Dutch Initiative on Crohn and Colitis.
    Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increasing healthcare costs in inflammatory bowel disease 2007-2020 in Sweden.
    Everhov ÅH, Söderling J, Befrits G, Khalili H, Bröms G, Neovius M, SWIBREG study group, Askling J, Halfvarson J, Ludvigsson JF, Olén O.
    Aliment Pharmacol Ther; 2023 Oct; 58(7):692-703. PubMed ID: 37594381
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015.
    Vadstrup K, Alulis S, Borsi A, Gustafsson N, Nielsen A, Wennerström ECM, Jørgensen TR, Qvist N, Munkholm P.
    Inflamm Bowel Dis; 2020 Aug 20; 26(9):1377-1382. PubMed ID: 31693731
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.
    Schoepfer A, Vavricka SR, Brüngger B, Reich O, Blozik E, Bähler C.
    Eur J Gastroenterol Hepatol; 2018 Aug 20; 30(8):868-875. PubMed ID: 29757772
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: evidence from a US national survey.
    Gunnarsson C, Chen J, Rizzo JA, Ladapo JA, Lofland JH.
    Dig Dis Sci; 2012 Dec 20; 57(12):3080-91. PubMed ID: 22790905
    [Abstract] [Full Text] [Related]

  • 13. Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
    Eriksson JK, Johansson K, Askling J, Neovius M.
    Ann Rheum Dis; 2015 Apr 20; 74(4):648-54. PubMed ID: 24323395
    [Abstract] [Full Text] [Related]

  • 14. Savings in social expenditures for work incapacity in patients with inflammatory bowel disease depend on access to innovative therapies in Poland.
    Zagórowicz E, Binowski G, Strządała D, Pruszko C, Kucha P, Reguła J.
    Eur J Gastroenterol Hepatol; 2024 Jun 01; 36(6):695-703. PubMed ID: 38526938
    [Abstract] [Full Text] [Related]

  • 15. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J.
    Dan Med J; 2014 Jan 01; 61(1):B4778. PubMed ID: 24393595
    [Abstract] [Full Text] [Related]

  • 16. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, Kim SC, Lawton RC, Murphy SM, Regueiro M, Rubin DT, Engel-Nitz NM, Heller CA.
    Inflamm Bowel Dis; 2020 Jan 01; 26(1):1-10. PubMed ID: 31112238
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J, Vardi H, Schwartz D, Friger M, Kiudelis G, Kupčinskas J, Fumery M, Gower-Rousseau C, Lakatos L, Lakatos PL, D'Incà R, Sartini A, Valpiani D, Giannotta M, Arebi N, Duricova D, Bortlik M, Chetcuti Zammit S, Ellul P, Pedersen N, Kjeldsen J, Midjord JMM, Nielsen KR, Winther Andersen K, Andersen V, Katsanos KH, Christodoulou DK, Domislovic V, Krznaric Z, Sebastian S, Oksanen P, Collin P, Barros L, Magro F, Salupere R, Kievit HAL, Goldis A, Kaimakliotis IP, Dahlerup JF, Eriksson C, Halfvarson J, Fernandez A, Hernandez V, Turcan S, Belousova E, Langholz E, Munkholm P, Odes S, Epi-IBD group.
    Lancet Gastroenterol Hepatol; 2020 May 01; 5(5):454-464. PubMed ID: 32061322
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data.
    Long GH, Tatro AR, Oh YS, Reddy SR, Ananthakrishnan AN.
    Adv Ther; 2019 Nov 01; 36(11):3079-3095. PubMed ID: 31562607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.